
Stephen E. Jones
Examiner (ID: 2262, Phone: (571)272-1762 , Office: P/2842 )
| Most Active Art Unit | 2817 |
| Art Unit(s) | 2843, 2842, 2817 |
| Total Applications | 2057 |
| Issued Applications | 1739 |
| Pending Applications | 89 |
| Abandoned Applications | 263 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 16948404
[patent_doc_number] => 20210207095
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-08
[patent_title] => METHODS OF ACTIVATING CELLS VIA PTP 1B INHIBITION
[patent_app_type] => utility
[patent_app_number] => 17/058551
[patent_app_country] => US
[patent_app_date] => 2019-05-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14629
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -30
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17058551
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/058551 | METHODS OF ACTIVATING CELLS VIA PTP 1B INHIBITION | May 30, 2019 | Pending |
Array
(
[id] => 14963789
[patent_doc_number] => 20190309373
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-10-10
[patent_title] => CANCER DIAGNOSIS, TREATMENT SELECTION AND TREATMENT
[patent_app_type] => utility
[patent_app_number] => 16/404204
[patent_app_country] => US
[patent_app_date] => 2019-05-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 39386
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -3
[patent_words_short_claim] => 47
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16404204
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/404204 | CANCER DIAGNOSIS, TREATMENT SELECTION AND TREATMENT | May 5, 2019 | Abandoned |
Array
(
[id] => 17020874
[patent_doc_number] => 20210244745
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-08-12
[patent_title] => COMBINATION COMPOSITIONS COMPRISING BISFLUOROALKYL-1,4-BENZODIAZEPINONE COMPOUNDS AND METHODS OF USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/052812
[patent_app_country] => US
[patent_app_date] => 2019-05-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13667
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17052812
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/052812 | COMBINATION COMPOSITIONS COMPRISING BISFLUOROALKYL-1,4-BENZODIAZEPINONE COMPOUNDS AND METHODS OF USE THEREOF | May 4, 2019 | Abandoned |
Array
(
[id] => 15083335
[patent_doc_number] => 20190336478
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-11-07
[patent_title] => STABLE ORAL LIQUID COMPOSITIONS OF ENALAPRIL
[patent_app_type] => utility
[patent_app_number] => 16/403444
[patent_app_country] => US
[patent_app_date] => 2019-05-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2513
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16403444
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/403444 | STABLE ORAL LIQUID COMPOSITIONS OF ENALAPRIL | May 2, 2019 | Abandoned |
Array
(
[id] => 15020729
[patent_doc_number] => 20190321369
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-10-24
[patent_title] => ICOTINIB-CONTAINING TOPICAL SKIN PHARMACEUTICAL COMPOSITIONS AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/398827
[patent_app_country] => US
[patent_app_date] => 2019-04-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7046
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -32
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16398827
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/398827 | ICOTINIB-CONTAINING TOPICAL SKIN PHARMACEUTICAL COMPOSITIONS AND USE THEREOF | Apr 29, 2019 | Abandoned |
Array
(
[id] => 15646507
[patent_doc_number] => 20200085783
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-03-19
[patent_title] => PALYTOXYN, ITS MEDICAL USE AND PROCESS FOR ITS ISOLATION
[patent_app_type] => utility
[patent_app_number] => 16/399432
[patent_app_country] => US
[patent_app_date] => 2019-04-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14036
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16399432
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/399432 | PALYTOXYN, ITS MEDICAL USE AND PROCESS FOR ITS ISOLATION | Apr 29, 2019 | Abandoned |
Array
(
[id] => 17330051
[patent_doc_number] => 11220504
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-01-11
[patent_title] => Pyrrolo[3,2-d] pyrimidine derivatives for the treatment of viral infections and other diseases
[patent_app_type] => utility
[patent_app_number] => 16/382727
[patent_app_country] => US
[patent_app_date] => 2019-04-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24282
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16382727
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/382727 | Pyrrolo[3,2-d] pyrimidine derivatives for the treatment of viral infections and other diseases | Apr 11, 2019 | Issued |
Array
(
[id] => 15589605
[patent_doc_number] => 20200071337
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-03-05
[patent_title] => ANTIVIRAL COMPOUNDS
[patent_app_type] => utility
[patent_app_number] => 16/378089
[patent_app_country] => US
[patent_app_date] => 2019-04-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 44145
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -3
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16378089
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/378089 | ANTIVIRAL COMPOUNDS | Apr 7, 2019 | Abandoned |
Array
(
[id] => 14649213
[patent_doc_number] => 20190231735
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-08-01
[patent_title] => METHODS FOR TREATING CANCER
[patent_app_type] => utility
[patent_app_number] => 16/363427
[patent_app_country] => US
[patent_app_date] => 2019-03-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10583
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16363427
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/363427 | METHODS FOR TREATING CANCER | Mar 24, 2019 | Abandoned |
Array
(
[id] => 14578307
[patent_doc_number] => 20190216762
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-07-18
[patent_title] => VEGETARIAN COMPOSITION CONTAINING UNSATURATED FATTY ACIDS
[patent_app_type] => utility
[patent_app_number] => 16/361711
[patent_app_country] => US
[patent_app_date] => 2019-03-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3067
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -2
[patent_words_short_claim] => 139
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16361711
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/361711 | VEGETARIAN COMPOSITION CONTAINING UNSATURATED FATTY ACIDS | Mar 21, 2019 | Abandoned |
Array
(
[id] => 17073747
[patent_doc_number] => 11110126
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-09-07
[patent_title] => Method of expanding NK cell and composition for culturing
[patent_app_type] => utility
[patent_app_number] => 16/281372
[patent_app_country] => US
[patent_app_date] => 2019-02-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 9
[patent_no_of_words] => 5198
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16281372
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/281372 | Method of expanding NK cell and composition for culturing | Feb 20, 2019 | Issued |
Array
(
[id] => 14435407
[patent_doc_number] => 20190175575
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-06-13
[patent_title] => METHODS AND COMPOSITIONS USING IMMUNOMODULATORY COMPOUNDS FOR TREATMENT AND MANAGEMENT OF CANCERS AND OTHER DISEASES
[patent_app_type] => utility
[patent_app_number] => 16/277936
[patent_app_country] => US
[patent_app_date] => 2019-02-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17773
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16277936
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/277936 | METHODS AND COMPOSITIONS USING IMMUNOMODULATORY COMPOUNDS FOR TREATMENT AND MANAGEMENT OF CANCERS AND OTHER DISEASES | Feb 14, 2019 | Abandoned |
Array
(
[id] => 14435471
[patent_doc_number] => 20190175607
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-06-13
[patent_title] => Method of maintaining oral health in animals
[patent_app_type] => utility
[patent_app_number] => 16/277893
[patent_app_country] => US
[patent_app_date] => 2019-02-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4518
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16277893
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/277893 | Method of maintaining oral health in animals | Feb 14, 2019 | Issued |
Array
(
[id] => 14712673
[patent_doc_number] => 20190247400
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-08-15
[patent_title] => CERTAIN (2S)-N-[(1S)-1-CYANO-2-PHENYLETHYL]-1,4-OXAZEPANE-2-CARBOXAMIDES FOR TREATING GRANULOMATOSIS WITH POLYANGIITIS
[patent_app_type] => utility
[patent_app_number] => 16/269191
[patent_app_country] => US
[patent_app_date] => 2019-02-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13498
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -170
[patent_words_short_claim] => 116
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16269191
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/269191 | CERTAIN (2S)-N-[(1S)-1-CYANO-2-PHENYLETHYL]-1,4-OXAZEPANE-2-CARBOXAMIDES FOR TREATING GRANULOMATOSIS WITH POLYANGIITIS | Feb 5, 2019 | Abandoned |
Array
(
[id] => 16619949
[patent_doc_number] => 20210038602
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-02-11
[patent_title] => COMBINATION TREATMENT OF ACUTE MYELOID LEUKEMIA
[patent_app_type] => utility
[patent_app_number] => 16/964023
[patent_app_country] => US
[patent_app_date] => 2019-01-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6188
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16964023
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/964023 | COMBINATION TREATMENT OF ACUTE MYELOID LEUKEMIA | Jan 23, 2019 | Abandoned |
Array
(
[id] => 14743815
[patent_doc_number] => 20190255081
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-08-22
[patent_title] => COMBINATION THERAPIES TARGETING MITOCHONDRIA FOR CANCER THERAPY
[patent_app_type] => utility
[patent_app_number] => 16/254919
[patent_app_country] => US
[patent_app_date] => 2019-01-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17247
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16254919
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/254919 | COMBINATION THERAPIES TARGETING MITOCHONDRIA FOR CANCER THERAPY | Jan 22, 2019 | Abandoned |
Array
(
[id] => 14309389
[patent_doc_number] => 20190144398
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-05-16
[patent_title] => METHOD FOR TREATING INFLAMMATORY DISORDERS
[patent_app_type] => utility
[patent_app_number] => 16/243578
[patent_app_country] => US
[patent_app_date] => 2019-01-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 68052
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16243578
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/243578 | METHOD FOR TREATING INFLAMMATORY DISORDERS | Jan 8, 2019 | Abandoned |
Array
(
[id] => 16397230
[patent_doc_number] => 20200338088
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-10-29
[patent_title] => Methods for Treating Neutrophilic Dermatoses with SYK Inhibitors
[patent_app_type] => utility
[patent_app_number] => 16/958924
[patent_app_country] => US
[patent_app_date] => 2019-01-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4841
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16958924
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/958924 | Methods for Treating Neutrophilic Dermatoses with SYK Inhibitors | Jan 3, 2019 | Abandoned |
Array
(
[id] => 14210551
[patent_doc_number] => 20190117660
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-04-25
[patent_title] => Pharmaceutical Compositions and Methods for Stabilizing the Same
[patent_app_type] => utility
[patent_app_number] => 16/229654
[patent_app_country] => US
[patent_app_date] => 2018-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5788
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16229654
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/229654 | Pharmaceutical Compositions and Methods for Stabilizing the Same | Dec 20, 2018 | Abandoned |
Array
(
[id] => 18746492
[patent_doc_number] => 11805776
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-11-07
[patent_title] => Compositions and methods for killing insect and non-insect pests
[patent_app_type] => utility
[patent_app_number] => 16/227192
[patent_app_country] => US
[patent_app_date] => 2018-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 10787
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 82
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16227192
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/227192 | Compositions and methods for killing insect and non-insect pests | Dec 19, 2018 | Issued |